Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Celgene announces fiscal 2009 third-quarter results

Celgene announces fiscal 2009 third-quarter results

Merck's sales increases by 2% in third quarter 2009

Merck's sales increases by 2% in third quarter 2009

GeneNews announces the publication of a paper in the Journal of Clinical Gastroenterology

GeneNews announces the publication of a paper in the Journal of Clinical Gastroenterology

Decrease in sales for CONMED Corporation during third quarter ended September 30, 2009

Decrease in sales for CONMED Corporation during third quarter ended September 30, 2009

Schering-Plough announces 2009 third quarter financial results

Schering-Plough announces 2009 third quarter financial results

Pharmos announces results of its Phase 2b Dextofisopam trial

Pharmos announces results of its Phase 2b Dextofisopam trial

LANL and international researchers propose new genome sequence strategies

LANL and international researchers propose new genome sequence strategies

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Lactose intolerance rates may be overestimated by wide margins

Lactose intolerance rates may be overestimated by wide margins

Logical Therapeutics to present its clinical study results on LT-NS001

Logical Therapeutics to present its clinical study results on LT-NS001

School meal programs should adopt new set of nutrient targets, says IOM

School meal programs should adopt new set of nutrient targets, says IOM

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

Clonality analyses may lead to further understanding of hepatocarcinogenesis

Clonality analyses may lead to further understanding of hepatocarcinogenesis

RA patients who adhere to their prescription drug regimen have better outcome: Study

RA patients who adhere to their prescription drug regimen have better outcome: Study

Age, gender and malignancies pose significant risk factors for TIVADs survival

Age, gender and malignancies pose significant risk factors for TIVADs survival

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Data on ULORIC treatment for gout flares presented at the 73rd American College of Rheumatology meeting

Data on ULORIC treatment for gout flares presented at the 73rd American College of Rheumatology meeting

Encorium Group raises $1.6 million through private placement

Encorium Group raises $1.6 million through private placement

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

XenoPort commences Phase 2b arbaclofen placarbil clinical trial for treating gastroesophageal reflux disease

XenoPort commences Phase 2b arbaclofen placarbil clinical trial for treating gastroesophageal reflux disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.